CONTROVERSIA

This profile has not been translated into English yet. It is shown in French, the reference language (automatic translation tools in your browser can help). Legal statuses and counts are shown in English.

Portrait of Agilent Technologies

Portrait: Wikidata/Wikimedia Commons — See Wikimedia Commons source page · source

Sciences de la vie / diagnostics / instrumentation analytique / services de laboratoire

Agilent Technologies

Fiche documentée couvrant 18 controverses, dont « Annonce du spin-off des activités de mesure de Hewlett-Packard » et « Introduction en Bourse d’Agilent ».

Your opinion of this profile

Profile No. 5164 · Updated on 26 September 2026

18Documented controversies
13Sources
0Formal charge · all time
0Conviction

§ Legal statuses reflect the documented sources as of the date shown; they replace neither court decisions nor the presumption of innocence. Counts are not a rating. Methodology

I. Documented controversies

01

20 février 2025-15 mai 2026

Règlement OSHA sur les procédures de consignation des énergies dangereuses à Longmont

Status not specified

Not yet available in English — French original shown.

À la suite d’une inspection OSHA du site Agilent de Longmont, une citation initialement classée « Serious » est supprimée dans le règlement formel, tandis qu’une violation « Other » relative aux procédures écrites de lockout/tagout demeure avec une pénalité finale de 10 000 $. Le dossier est clôturé le 15 mai 2026.

Sources · 2

  1. [1]
    U.S. Occupational Safety and Health AdministrationInspection 1805318.015 — Agilent Technologies Inc.Very high reliability
  2. [2]
    U.S. Occupational Safety and Health AdministrationViolation Detail 01001B — Agilent Technologies Inc.Very high reliability

Last verified: 21 September 2026

02

20 septembre 2024

Acquisition de BIOVECTRA

Status not specified

Not yet available in English — French original shown.

Agilent acquiert 100 % de BIOVECTRA pour 915 M$ en numéraire afin d’élargir son activité CDMO.

Legal status — source text
completed

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2025 Form 10-KVery high reliability

Last verified: 21 September 2026

03

2023

Impairment puis sortie de Resolution Bioscience

Status not specified

Not yet available in English — French original shown.

Agilent décide de sortir de Resolution Bioscience, comptabilise une dépréciation de 270 M$ puis accepte une offre non sollicitée et cède l’activité pour 50 M$.

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2025 annual report – Resolution Bioscience divestiture disclosureVery high reliability

Last verified: 21 September 2026

04

2022

Acquisition de Polymer Standards Service

Status not specified

Not yet available in English — French original shown.

Agilent acquiert Polymer Standards Service, spécialiste de la caractérisation des polymères, pour environ 41 M$.

Legal status — source text
completed

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2022 acquisition noteVery high reliability

Last verified: 21 September 2026

05

15 avril 2021

Acquisition de Resolution Bioscience

Status not specified

Not yet available in English — French original shown.

Agilent acquiert Resolution Bioscience pour environ 561 M$ en numéraire plus paiements conditionnels, afin de renforcer les diagnostics oncologiques NGS.

Legal status — source text
completed

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2021 Form 10-KVery high reliability

Last verified: 21 September 2026

06

23 août 2019

Acquisition de BioTek

Status not specified

Not yet available in English — French original shown.

Agilent acquiert BioTek pour environ 1,17 Md$, développant son portefeuille d’instrumentation de sciences de la vie et d’analyse cellulaire.

Legal status — source text
completed

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2019 Form 10-KVery high reliability

Last verified: 21 September 2026

07

2018

Acquisition d’Advanced Analytical Technologies

Status not specified

Not yet available in English — French original shown.

Agilent acquiert Advanced Analytical Technologies dans le cadre d’une série d’opérations 2018, renforçant l’analyse des biomolécules.

Legal status — source text
completed

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2019 Form 10-KVery high reliability

Last verified: 21 September 2026

08

14 novembre 2018

Acquisition d’ACEA Biosciences

Status not specified

Not yet available in English — French original shown.

Agilent acquiert ACEA Biosciences pour environ 250 M$, renforçant ses outils d’analyse cellulaire.

Legal status — source text
completed

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2019 Form 10-KVery high reliability

Last verified: 21 September 2026

09

19 mai 2015

Acquisition de Cartagenia

Status not specified

Not yet available in English — French original shown.

Agilent acquiert Cartagenia, fournisseur de logiciels de génomique clinique et de pathologie moléculaire, pour environ 60 M€.

Legal status — source text
completed

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2015 Form 10-KVery high reliability

Last verified: 21 September 2026

10

2 novembre 2015

Acquisition de Seahorse Bioscience

Status not specified

Not yet available in English — French original shown.

Agilent acquiert Seahorse Bioscience pour 242 M$, ajoutant des instruments et essais de mesure du métabolisme cellulaire.

Legal status — source text
completed

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2015 Form 10-KVery high reliability

Last verified: 21 September 2026

11

1er novembre 2014

Spin-off de Keysight Technologies

Status not specified

Not yet available in English — French original shown.

Agilent distribue 100 % des actions de Keysight à ses actionnaires et sépare ses activités de mesure électronique.

Legal status — source text
completed

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2014 Form 10-KVery high reliability

Last verified: 21 September 2026

12

21 juin 2012

Acquisition de Dako

Status not specified

Not yet available in English — French original shown.

Agilent acquiert Dako pour environ 2,143 Md$, renforçant l’anatomopathologie et le diagnostic moléculaire, notamment en oncologie.

Legal status — source text
completed

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2014 Form 10-KVery high reliability

Last verified: 21 September 2026

13

14 mai 2010

Acquisition de Varian avec remèdes antitrust

Status not specified

Not yet available in English — French original shown.

Agilent finalise l’acquisition de Varian pour environ 1,5 Md$, après engagements de cession concernant plusieurs lignes d’instruments scientifiques.

Sources · 2

  1. [1]
    Federal Trade CommissionFTC Order Preserves Competition Threatened by Agilent Acquisition of VarianVery high reliability
  2. [2]
    U.S. Securities and Exchange CommissionAgilent 2010 Form 10-KVery high reliability

Last verified: 21 September 2026

14

mai 2010

Cessions de lignes d’instruments liées à Varian

Status not specified

Not yet available in English — French original shown.

Agilent et Varian cèdent les activités GC de laboratoire, GC-MS triple quadrupôle, ICP-MS et micro-GC requises dans le cadre des autorisations antitrust.

Legal status — source text
completed

Sources · 2

  1. [1]
    Federal Trade CommissionFTC Order Preserves Competition Threatened by Agilent Acquisition of VarianVery high reliability
  2. [2]
    U.S. Securities and Exchange CommissionAgilent 2010 Form 10-KVery high reliability

Last verified: 21 September 2026

15

1er mai 2010

Cession de Network Solutions Division à JDSU

Status not specified

Not yet available in English — French original shown.

Agilent cède la Network Solutions Division de son activité electronic measurement à JDS Uniphase.

Legal status — source text
completed

Sources · 1

  1. [1]
    U.S. Securities and Exchange CommissionAgilent 2010 Form 10-KVery high reliability

Last verified: 21 September 2026

16

2000

Séparation complète de Hewlett-Packard

Status not specified

Not yet available in English — French original shown.

Agilent devient pleinement indépendante de Hewlett-Packard après la séparation initiée en 1999.

Legal status — source text
completed

Sources · 1

  1. [1]
    Agilent TechnologiesAgilent Company HistoryVery high reliability

Last verified: 21 September 2026

17

1999

Annonce du spin-off des activités de mesure de Hewlett-Packard

No legal proceedings

Not yet available in English — French original shown.

Hewlett-Packard annonce la création d’une société indépendante regroupant test et mesure, composants, analyse chimique et activités médicales sous le nom Agilent Technologies.

Legal status — source text
Not applicable

Sources · 1

  1. [1]
    Agilent TechnologiesAgilent History Timeline – 1999Very high reliability

Last verified: 21 September 2026

18

18 novembre 1999

Introduction en Bourse d’Agilent

Status not specified

Not yet available in English — French original shown.

Agilent réalise une IPO de 2,1 Md$, alors présentée comme la plus importante de l’histoire de la Silicon Valley.

Legal status — source text
completed

Sources · 1

  1. [1]
    Agilent TechnologiesAgilent History Timeline – 1999Very high reliability

Last verified: 21 September 2026

II. Constellation of documented links

Each link refers to an imported relation or to a documented mention in a profile. A documented mention does not, on its own, prove a personal relationship.

List of documented links
  1. Keysight Technologies1 reference
    • Mentioned in “Spin-off de Keysight Technologies” — Agilent Technologies's profile cites Keysight Technologies.

III. Your opinion of this profile

One opinion per browser, which you can change at any time. It rates the quality of the profile, not the person.

IV. Has something changed?

A new court decision, a missing source, a mistake? Tell us what should be updated: every request is read by the editorial team.

Update request

Agilent Technologies

Say which controversy is concerned and, if possible, give a source. Between 10 and 2,500 characters.

0 / 2500